CytoDyn Welcomes Dr. Shan Lu To Its Scientific Advisory Board

SANTA FE, N.M. & WORCESTER, Mass.--(BUSINESS WIRE)--CytoDyn, Inc. (Pink Sheets:CYDY) has appointed Shan Lu, MD, PhD, to its Scientific Advisory Board. Dr. Lu, who is a Professor of Medicine at the University of Massachusetts Medical School (UMMS) in Worcester, Massachusetts, is the lead inventor of the DNA-based pre-flu vaccine being developed by Advanced Influenza Technologies, Inc., a wholly owned subsidiary of CytoDyn, Inc. The pre-flu vaccine is designed to provide protection against multiple strains of the flu virus, including the seasonal flu and the bird flu, all in one shot that can be given at any time of the year.

Back to news